A 25 year old overweight female was given fentanyl-pancuronium anesthesia for surgery. After surgery and extubation she was observed to have limited movement of the upper body and chest wall in the recovery room. She was Conscious and ale but voluntary respiratory effo has limited. Her blood pressure and hea rate were normal. The likely diagnosis is
First, I need to recall the drugs used. Fentanyl is an opioid, and pancuronium is a neuromuscular blocking agent (NMB). The key here is the residual effects of these drugs post-surgery. Since she's conscious, it's unlikely to be a central nervous system issue. The limited movement and respiration point towards residual neuromuscular blockade.
Pancuronium is a non-depolarizing NMB, which blocks acetylcholine receptors at the neuromuscular junction. If the block hasn't fully reversed, she would have muscle weakness, especially in the diaphragm and intercostal muscles, leading to limited chest wall movement and respiration. Overweight patients might have a higher risk of residual blockade due to altered drug distribution or metabolism.
Now, looking at the options, even though they're not listed, the correct answer is likely residual neuromuscular blockade from pancuronium. The other possibilities might include opioid effects, but fentanyl's main effect is respiratory depression, which would affect all muscles and might not spare chest wall movement as much. Also, if it were an opioid issue, she might have more generalized depression, but the question specifies limited movement of upper body and chest wall, which is more localized to the muscles involved in breathing.
Another differential could be a phrenic nerve injury or diaphragmatic paralysis, but those are less likely post-anesthesia unless there was an iatrogenic injury. The fact that she's conscious rules out brainstem issues. Also, if it were a spinal anesthesia complication, the presentation would be different, with possible sensory loss and flaccid paralysis, but the question mentions voluntary effort is limited, which aligns more with residual NMB.
So the core concept here is residual neuromuscular blockade from pancuronium. The correct answer would be related to that. The incorrect options would involve other causes like opioid toxicity, spinal issues, or other neurological deficits. The clinical pearl is that residual NMB can present with isolated respiratory and upper body weakness post-surgery, especially in patients with risk factors like obesity, and should be monitored closely in the recovery room.
**Core Concept**
Non-depolarizing neuromuscular blocking agents like pancuronium competitively inhibit acetylcholine at nicotinic receptors at the neuromuscular junction, leading to flaccid paralysis. Residual blockade after surgery can manifest as isolated weakness of respiratory and axial muscles, sparing consciousness and vital signs.
**Why the Correct Answer is Right**
Pancuronium is a non-depolarizing neuromuscular blocker with anticholinergic properties. Residual blockade after surgery can cause diaphragm and intercostal muscle weakness, limiting chest wall movement and voluntary respiration despite intact consciousness. The patient’s normal heart rate and blood pressure suggest intact autonomic function, which is not affected by neuromuscular blockers. Overweight patients may have prolonged effects due to altered drug distribution or metabolism.
**Why Each Wrong Option is Incorrect**
**Option A:** Opioid toxicity (